Raily Aesthetic Medicine International Holdings (HKSE:02135) Cash-to-Debt : 1.14 (As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Raily Aesthetic Medicine International Holdings Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Raily Aesthetic Medicine International Holdings's cash to debt ratio for the quarter that ended in Jun. 2023 was 1.14.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Raily Aesthetic Medicine International Holdings could pay off its debt using the cash in hand for the quarter that ended in Jun. 2023.

The historical rank and industry rank for Raily Aesthetic Medicine International Holdings's Cash-to-Debt or its related term are showing as below:

HKSE:02135' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.62 Med: 1.72 Max: 4.63
Current: 0.77

During the past 7 years, Raily Aesthetic Medicine International Holdings's highest Cash to Debt Ratio was 4.63. The lowest was 0.62. And the median was 1.72.

HKSE:02135's Cash-to-Debt is ranked better than
53.11% of 659 companies
in the Healthcare Providers & Services industry
Industry Median: 0.66 vs HKSE:02135: 0.77

Raily Aesthetic Medicine International Holdings Cash-to-Debt Historical Data

The historical data trend for Raily Aesthetic Medicine International Holdings's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Raily Aesthetic Medicine International Holdings Cash-to-Debt Chart

Raily Aesthetic Medicine International Holdings Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

1.81

4.61

1.80

1.63

0.77

Raily Aesthetic Medicine International Holdings Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial							1.80	1.92	1.63	1.14	0.77

Competitive Comparison of Raily Aesthetic Medicine International Holdings's Cash-to-Debt

For the Medical Care Facilities subindustry, Raily Aesthetic Medicine International Holdings's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Raily Aesthetic Medicine International Holdings's Cash-to-Debt Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raily Aesthetic Medicine International Holdings's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Raily Aesthetic Medicine International Holdings's Cash-to-Debt falls into.

Raily Aesthetic Medicine International Holdings Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Raily Aesthetic Medicine International Holdings's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	87.974	/	(15.261	+	38.588)
	=	1.63

Raily Aesthetic Medicine International Holdings's Cash to Debt Ratio for the quarter that ended in Jun. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	65.239	/	(21.798	+	35.511)
	=	1.14

Raily Aesthetic Medicine International Holdings (HKSE:02135) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Raily Aesthetic Medicine International Holdings Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Raily Aesthetic Medicine International Holdings's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Raily Aesthetic Medicine International Holdings (HKSE:02135) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raily Aesthetic Medicine International Holdings Ltd (HKSE:02135) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 290 North Zhongshan Road, 3-5th Floor, Minhang Tower, Gongshu District, Hangzhou, CHN

Website

http://m.raily.com

Raily Aesthetic Medicine International Holdings Ltd is an aesthetic medical service provider in Zhejiang Province, the PRC. It offers a broad range of aesthetic medical services to clients to meet their different aesthetic and anti-aging objectives. The group is organized into business units based on their services and has three reportable operating segments namely Aesthetic medical services which comprise principally inpatient services including surgical services and outpatient services including injection service, dermatology services, and others; and Consulting service segment which comprise principally management consulting services. Aesthetic medical equipment products comprise principally sales of surgical implants and aesthetic medical skincare products.

Raily Aesthetic Medicine International Holdings (HKSE:02135) Headlines

No Headlines